Higher fatty liver index is associated with increased risk of new onset heart failure in healthy adults: A nationwide population-based study in Korea
Authors:
Preprint
- 13 February 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Heart failure (HF) is relatively common cardiovascular disease with high mortality and morbidity. Although it is associated with many cardiovascular risk factors, the association between nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease, and HF has not been evaluated in a large-scale cohort study. Thus, we evaluated the ability of the fatty liver Index (FLI), a surrogate marker of NAFLD, to predict the development of HF in healthy individuals. Methods We evaluated 308,578 healthy persons without comorbidities who underwent the National Health check-ups in the republic of Korea from 2009 to 2014. The association between the FLI and HF was analyzed using multivariate Cox proportional-hazards models. Results During a median of 5.4 years’ follow-up, 2,532 subjects (0.8%) were newly diagnosed with HF. Subjects were categorized into quartile groups according to FLI (Q1, 0-4.9; Q2, 5.0-12.5; Q3, 12.6-31.0; and Q4, >31.0). The cumulative incidence of HF was significantly higher in subjects with the highest FLI than in those with the lowest FLI (Q1, 307 [0.4%] and Q4, 890 [1.2%]; P<0.001). Adjusted hazard ratios (HRs) indicated that the highest FLI was independently associated with an increased risk for HF (HR between Q4 and Q1, 2.709; 95% confidence interval=2.380-3.085; P<0.001). FLI was significantly associated with increased risk of new-onset HF regardless of their baseline characteristics. Conclusions Higher FLI was independently associated with increased risk of HF in healthy Korean population.Keywords
All Related Versions
- Published version: BMC Cardiovascular Disorders, 20 (1), 1.
This publication has 38 references indexed in Scilit:
- Sympathetic Nervous System Catecholamines and Neuropeptide Y Neurotransmitters Are Upregulated in Human NAFLD and Modulate the Fibrogenic Function of Hepatic Stellate CellsPLOS ONE, 2013
- Oxidative Stress in Heart Failure: What Are We Missing?The American Journal of the Medical Sciences, 2011
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2010
- Serum γ-Glutamyl Transferase and Risk of Heart Failure in the CommunityArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Liver fibrosis: a balance of ACEs?Clinical Science, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Insulin Resistance and HypertensionHypertension, 2004
- Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2002
- Endotoxin and immune activation in chronic heart failure: a prospective cohort studyThe Lancet, 1999
- A ROLE FOR INSULIN IN THE AETIOLOGY AND COURSE OF HYPERTENSION?The Lancet, 1987